Monday, July 24, 2017 11:20:22 PM
Fundamental Indicators
Current ML Capital financial ratios
Current Valuation 366.34 K
Shares Outstanding 24.34 M
Price to Sales 0.10 times
Revenue 50.56 K
Gross Profit 81.52 K
Net Income (2.18 M)
Cash and Equivalents 10.64 K
Cash per Share 0.05 times
Total Debt 374.54 K
Current Ratio 0.04 times
Book Value Per Share (3.29) times
Cash Flow from Operations (565.51 K)
Earnings Per Share (27.17) times
Beta 35.21
Market Capitalization 4.87 K
Total Asset 3 K
Retained Earnings (12.89 M)
Working Capital (1.44 M)
Current Asset 2 K
Curren
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM